Barr Cleared Of Infringing Three Patents In Allegra Case
A U.S. district court has cleared Barr Laboratories of infringing three patents at the center of the generic drug maker's challenge involving Aventis' Allegra blockbuster allergy drug....To view the full article, register now.
Already a subscriber? Click here to view full article